Epidermal Growth Factor Protects Against High Glucose-Induced Podocyte Injury Possibly via Modulation of Autophagy and PI3K/AKT/mTOR Signaling Pathway Through DNA Methylation

Yan Sun,1 Ming Deng,2 Xiao Ke,2 Xiangyang Lei,3 Hao Ju,3 Zhiming Liu,3 Xiaosu Bai3,4 1Department of Endocrinology, Southern University of Science and Technology Hospital, Shenzhen, People’s Republic of China; 2Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences, S...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sun Y, Deng M, Ke X, Lei X, Ju H, Liu Z, Bai X
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/b8334e13f02a45afb3ae209f2a4e573c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b8334e13f02a45afb3ae209f2a4e573c
record_format dspace
institution DOAJ
collection DOAJ
language EN
topic diabetic nephropathy
epidermal growth factor
podocyte injury
autophagy
dna methylation
pi3k/akt/mtor
Specialties of internal medicine
RC581-951
spellingShingle diabetic nephropathy
epidermal growth factor
podocyte injury
autophagy
dna methylation
pi3k/akt/mtor
Specialties of internal medicine
RC581-951
Sun Y
Deng M
Ke X
Lei X
Ju H
Liu Z
Bai X
Epidermal Growth Factor Protects Against High Glucose-Induced Podocyte Injury Possibly via Modulation of Autophagy and PI3K/AKT/mTOR Signaling Pathway Through DNA Methylation
description Yan Sun,1 Ming Deng,2 Xiao Ke,2 Xiangyang Lei,3 Hao Ju,3 Zhiming Liu,3 Xiaosu Bai3,4 1Department of Endocrinology, Southern University of Science and Technology Hospital, Shenzhen, People’s Republic of China; 2Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences, Shenzhen Sun Yat-Sen Cardiovascular Hospital, Shenzhen, 518057, People’s Republic of China; 3Department of Endocrinology, Affiliated Longhua People’s Hospital, Southern Medical University, Longhua People’s Hospital, Shenzhen, People’s Republic of China; 4Department of General Practice; Affiliated Longhua People’s Hospital, Southern Medical University, Longhua People’s Hospital, Shenzhen, People’s Republic of ChinaCorrespondence: Xiaosu BaiAffiliated Longhua People’s Hospital, Southern Medical University, Longhua People’s Hospital, No. 2, Jianshe East Road, Bao’an District, Shenzhen, 518109, People’s Republic of ChinaTel +86-755-27741585Email bxsllb@163.comAim: Diabetic nephropathy (DN) is a serious health problem worldwide. Epidermal growth factor (EGF) has suggested as a potential biomarker for the progression of chronic kidney disease. In this study, we examined the effects of EGF on the high glucose (HG)-induced podocyte injury and explored the underlying molecular mechanisms.Methods: The cell proliferation, toxicity, and cell apoptosis of podocytes were determined by CCK-8 assay, lactate dehydrogenase release assay, and flow cytometry, respectively, and protein levels in the podocytes were determined by Western blot assay. Mechanistically, DNA methylation analysis, bioinformatic analysis, methylation‑specific PCR and quantitative real-time PCR were used to analyze functional pathways in differentially methylated genes and the expression of the key methylated genes in the podocytes after different interventions.Results: EGF treatment significantly increased the protein expression level of LC3 and decreased the protein level of P62 in HG-stimulated podocytes, which was attenuated by autophagy inhibitor, 3-methyladenine. EGF increased the cell proliferation and the protein expression levels of nephrin and synaptopodin, but reduced cell toxicity and cell apoptosis and protein expression level of cleaved caspase-3, which was partially antagonized by 3-methyladenine. DNA methylation expression profiles revealed the differential hypermethylation sites and hypomethylation sites among podocytes treated with normal glucose, HG and HG+EGF. GO enrichment analysis showed that DNA methylation was significantly enriched in negative regulation of phosphorylation, cell-cell junction and GTPase binding. KEGG pathway analysis showed that these genes were mainly enriched in PI3K-Akt, Hippo and autophagy pathways. Further validation studies revealed that six hub genes (ITGB1, GRB2, FN1, ITGB3, FZD10 and FGFR1) may be associated with the protective effects of EGF on the HG-induced podocyte injury.Conclusion: In summary, our results demonstrated that EGF exerted protective effects on HG-induced podocytes injury via enhancing cell proliferation and inhibiting cell apoptosis. Further mechanistic studies implied that EGF-mediated protective effects in HG-stimulated podocytes may be associated with modulation of autophagy and PI3K/AKT/mTOR signaling pathway.Keywords: diabetic nephropathy, epidermal growth factor, podocyte injury, autophagy, DNA methylation, PI3K/AKT/mTOR
format article
author Sun Y
Deng M
Ke X
Lei X
Ju H
Liu Z
Bai X
author_facet Sun Y
Deng M
Ke X
Lei X
Ju H
Liu Z
Bai X
author_sort Sun Y
title Epidermal Growth Factor Protects Against High Glucose-Induced Podocyte Injury Possibly via Modulation of Autophagy and PI3K/AKT/mTOR Signaling Pathway Through DNA Methylation
title_short Epidermal Growth Factor Protects Against High Glucose-Induced Podocyte Injury Possibly via Modulation of Autophagy and PI3K/AKT/mTOR Signaling Pathway Through DNA Methylation
title_full Epidermal Growth Factor Protects Against High Glucose-Induced Podocyte Injury Possibly via Modulation of Autophagy and PI3K/AKT/mTOR Signaling Pathway Through DNA Methylation
title_fullStr Epidermal Growth Factor Protects Against High Glucose-Induced Podocyte Injury Possibly via Modulation of Autophagy and PI3K/AKT/mTOR Signaling Pathway Through DNA Methylation
title_full_unstemmed Epidermal Growth Factor Protects Against High Glucose-Induced Podocyte Injury Possibly via Modulation of Autophagy and PI3K/AKT/mTOR Signaling Pathway Through DNA Methylation
title_sort epidermal growth factor protects against high glucose-induced podocyte injury possibly via modulation of autophagy and pi3k/akt/mtor signaling pathway through dna methylation
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/b8334e13f02a45afb3ae209f2a4e573c
work_keys_str_mv AT suny epidermalgrowthfactorprotectsagainsthighglucoseinducedpodocyteinjurypossiblyviamodulationofautophagyandpi3kaktmtorsignalingpathwaythroughdnamethylation
AT dengm epidermalgrowthfactorprotectsagainsthighglucoseinducedpodocyteinjurypossiblyviamodulationofautophagyandpi3kaktmtorsignalingpathwaythroughdnamethylation
AT kex epidermalgrowthfactorprotectsagainsthighglucoseinducedpodocyteinjurypossiblyviamodulationofautophagyandpi3kaktmtorsignalingpathwaythroughdnamethylation
AT leix epidermalgrowthfactorprotectsagainsthighglucoseinducedpodocyteinjurypossiblyviamodulationofautophagyandpi3kaktmtorsignalingpathwaythroughdnamethylation
AT juh epidermalgrowthfactorprotectsagainsthighglucoseinducedpodocyteinjurypossiblyviamodulationofautophagyandpi3kaktmtorsignalingpathwaythroughdnamethylation
AT liuz epidermalgrowthfactorprotectsagainsthighglucoseinducedpodocyteinjurypossiblyviamodulationofautophagyandpi3kaktmtorsignalingpathwaythroughdnamethylation
AT baix epidermalgrowthfactorprotectsagainsthighglucoseinducedpodocyteinjurypossiblyviamodulationofautophagyandpi3kaktmtorsignalingpathwaythroughdnamethylation
_version_ 1718381165158596608
spelling oai:doaj.org-article:b8334e13f02a45afb3ae209f2a4e573c2021-12-02T17:17:07ZEpidermal Growth Factor Protects Against High Glucose-Induced Podocyte Injury Possibly via Modulation of Autophagy and PI3K/AKT/mTOR Signaling Pathway Through DNA Methylation1178-7007https://doaj.org/article/b8334e13f02a45afb3ae209f2a4e573c2021-05-01T00:00:00Zhttps://www.dovepress.com/epidermal-growth-factor-protects-against-high-glucose-induced-podocyte-peer-reviewed-fulltext-article-DMSOhttps://doaj.org/toc/1178-7007Yan Sun,1 Ming Deng,2 Xiao Ke,2 Xiangyang Lei,3 Hao Ju,3 Zhiming Liu,3 Xiaosu Bai3,4 1Department of Endocrinology, Southern University of Science and Technology Hospital, Shenzhen, People’s Republic of China; 2Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences, Shenzhen Sun Yat-Sen Cardiovascular Hospital, Shenzhen, 518057, People’s Republic of China; 3Department of Endocrinology, Affiliated Longhua People’s Hospital, Southern Medical University, Longhua People’s Hospital, Shenzhen, People’s Republic of China; 4Department of General Practice; Affiliated Longhua People’s Hospital, Southern Medical University, Longhua People’s Hospital, Shenzhen, People’s Republic of ChinaCorrespondence: Xiaosu BaiAffiliated Longhua People’s Hospital, Southern Medical University, Longhua People’s Hospital, No. 2, Jianshe East Road, Bao’an District, Shenzhen, 518109, People’s Republic of ChinaTel +86-755-27741585Email bxsllb@163.comAim: Diabetic nephropathy (DN) is a serious health problem worldwide. Epidermal growth factor (EGF) has suggested as a potential biomarker for the progression of chronic kidney disease. In this study, we examined the effects of EGF on the high glucose (HG)-induced podocyte injury and explored the underlying molecular mechanisms.Methods: The cell proliferation, toxicity, and cell apoptosis of podocytes were determined by CCK-8 assay, lactate dehydrogenase release assay, and flow cytometry, respectively, and protein levels in the podocytes were determined by Western blot assay. Mechanistically, DNA methylation analysis, bioinformatic analysis, methylation‑specific PCR and quantitative real-time PCR were used to analyze functional pathways in differentially methylated genes and the expression of the key methylated genes in the podocytes after different interventions.Results: EGF treatment significantly increased the protein expression level of LC3 and decreased the protein level of P62 in HG-stimulated podocytes, which was attenuated by autophagy inhibitor, 3-methyladenine. EGF increased the cell proliferation and the protein expression levels of nephrin and synaptopodin, but reduced cell toxicity and cell apoptosis and protein expression level of cleaved caspase-3, which was partially antagonized by 3-methyladenine. DNA methylation expression profiles revealed the differential hypermethylation sites and hypomethylation sites among podocytes treated with normal glucose, HG and HG+EGF. GO enrichment analysis showed that DNA methylation was significantly enriched in negative regulation of phosphorylation, cell-cell junction and GTPase binding. KEGG pathway analysis showed that these genes were mainly enriched in PI3K-Akt, Hippo and autophagy pathways. Further validation studies revealed that six hub genes (ITGB1, GRB2, FN1, ITGB3, FZD10 and FGFR1) may be associated with the protective effects of EGF on the HG-induced podocyte injury.Conclusion: In summary, our results demonstrated that EGF exerted protective effects on HG-induced podocytes injury via enhancing cell proliferation and inhibiting cell apoptosis. Further mechanistic studies implied that EGF-mediated protective effects in HG-stimulated podocytes may be associated with modulation of autophagy and PI3K/AKT/mTOR signaling pathway.Keywords: diabetic nephropathy, epidermal growth factor, podocyte injury, autophagy, DNA methylation, PI3K/AKT/mTORSun YDeng MKe XLei XJu HLiu ZBai XDove Medical Pressarticlediabetic nephropathyepidermal growth factorpodocyte injuryautophagydna methylationpi3k/akt/mtorSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 14, Pp 2255-2268 (2021)